Clinical trial
High Dose Carboplatin Combined With Oral VP-16 In The Treatment Of Pediatric CNS Malignancies
NCT00053118 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- High Dose Carboplatin Combined With Oral VP-16 In The Treatment Of Pediatric CNS Malignancies
- Lead sponsor
- Roswell Park Cancer Institute
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 31, 2002
- Completion date
- July 31, 2004
- Enrollment
- 1 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
brain and central nervous system tumors, lymphoma, neuroblastoma, retinoblastoma